CCP obtained the approval of the II class psychoactive drug-Caffeine Tablets

On November 6, 2019, CCP obtained the approval document of experimental research for Caffeine Tablets from NMPA (approval No.: TYL2019-0240).

This approval is CCP's aother big progress before it starts bulk production. CCP will make ever-lasting efforts to hold the banner of innovation, develop and produce more reliable, safe and effective drugs to serve public's health.